background
immun
respons
viral
respiratori
tract
infect
vrti
includ
recruit
circul
neutrophil
lung
recruit
requir
cellular
activ
measur
surfac
express
littl
known
cell
surfac
express
vrti
aim
describ
express
circul
neutrophil
infant
hospit
vrti
method
hospit
infant
year
age
document
vrti
attribut
singl
viru
healthi
infant
control
includ
studi
obtain
inform
consent
whole
blood
collect
syring
coat
edta
neutrophil
express
determin
use
flow
cytometri
gate
granulocyt
follow
exposur
increas
concentr
nm
potent
induc
surfac
express
sampl
infant
vrti
seen
followup
week
postdischarg
whole
blood
obtain
visit
neutrophil
express
analysi
result
twelv
infant
vrti
includ
mean
age
day
rang
day
male
healthi
infant
includ
mean
age
day
rang
day
male
infant
diagnos
human
metapneumoviru
hmpv
respiratori
syncyti
viru
rsv
coronaviru
cov
neutrophil
infect
infant
exhibit
mean
fold
increas
rang
increas
concentr
gradient
stimul
compar
healthi
infant
control
exhibit
mean
fold
increas
rang
infant
rsv
hmpv
cov
seen
follow
neutrophil
infant
vrti
show
recoveri
express
stimul
week
discharg
conclus
circul
neutrophil
obtain
vrtinfect
infant
resist
associ
increas
surfac
express
suggest
even
prior
recruit
airway
circul
neutrophil
alreadi
highli
activ
disclosur
j
b
domachowsk
ii
glaxo
smith
kline
investig
research
grant
pfizer
investig
research
grant
astra
zeneca
investig
research
grant
novavax
investig
research
grant
